文献速递造血干细胞移植与细胞治疗

皮肤菌群失调是同种异体造血干细胞移植后的特征

Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period.
PubMed 文献 · Blood Adv · 2025-01-01

该研究对12例成人患者在预处理化疗/放疗前及同种异体造血干细胞移植后1周、1个月和3个月采集耳后和前臂皮肤拭子,行鸟枪法宏基因组测序,发现移植后皮肤微生物组富含革兰阴性菌、真菌和病毒,死亡患者中富集噬菌体和多瘤病毒,但真菌丰度与结局无关。

要点

  • 同种异体HSCT后皮肤微生物组富含大肠埃希菌和假单胞菌等革兰阴性菌、真菌和病毒。
  • 1年内死亡患者皮肤微生物组中观察到噬菌体和多瘤病毒富集,但真菌丰度与任何观察结局无关。
  • 移植后3个月时存活超过1年的患者皮肤微生物组呈现纵向稳定性,但可能仅反映患者整体医疗状态。

核心结论

  • 同种异体HSCT后存在皮肤菌群失调,皮肤微生物组可能是致病共生菌的储库,但其对患者结局的最终意义尚待更大规模研究。

研究设计与样本

  • 先导性观察研究,纳入12例成人患者,在预处理化疗/放疗前及同种异体HSCT后1周、1个月和3个月采集耳后和前臂皮肤拭子,行鸟枪法宏基因组测序。

主要发现

  • HSCT患者皮肤微生物组中大肠埃希菌和假单胞菌等革兰阴性菌、真菌和病毒富集。
  • 1年内死亡患者中观察到噬菌体和多瘤病毒物种富集。
  • 存活超过1年的患者移植后3个月时皮肤微生物组呈现纵向稳定性,但可能仅反映患者整体医疗状态。
  • 真菌丰度与所观察的任何结局均无关联。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gut dysbiosis is linked to mortality and the development of graft-versus-host disease after hematopoietic stem cell transplantation (HSCT), but the impact of cutaneous dysbiosis remains unexplored. We performed a pilot observational study, obtained retroauricular and forearm skin swabs from 12 adult patients before conditioning chemotherapy/radiation and at 1 week, 1 month, and 3 months after allogeneic HSCT, and performed shotgun metagenomic sequencing. The cutaneous microbiome among HSCT patients was enriched for gram-negative bacteria such as Escherichia coli and Pseudomonas, fungi, and viruses. Enrichment with bacteriophages and Polyomavirus species was observed among patients who died within 1 year. We observed longitudinal stability of the cutaneous microbiome at the 3-month time point among those who survived beyond 1 year after HSCT, although these may simply be a reflection of the overall medical status of the patients. There was no association with fungal abundance and any of the outcomes observed. The cutaneous microbiome may be a reservoir of pathobionts among allogeneic HSCT patients. Our findings suggest that cutaneous dysbiosis exists after HSCT, but the ultimate implication of this to patient outcomes remains to be seen through larger studies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cardones AR, Emiola A, Hall RP, et al. Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period. Blood Adv. 2025. PMID: 39853270. doi:10.1182/bloodadvances.2021004792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。